Apart from the very poor environment outlined in the commentary, even operating EBITDA margins took a hit (-2%), and accounting for the reversal of the impairment, there wasn't actually much growth at all in net profit. Poor to say the least. If they really think the issues flagged are a temporary issue, then the buyback should get going again. Hard to comprehend we were trying to bid for Integral Diagnostics not all that long ago.
CAJ, page-49
Add CAJ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $341.1M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 32.5¢ | 32.0¢ | $48.96K | 151.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 185480 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 1057790 | 21 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| CAJ (ASX) Chart |